EpiPen supplies returning to normal after year-long shortage

Widespread shortages of EpiPen, an epinephrine autoinjector for the treatment of anaphylaxis, have been resolved. The Therapeutic Goods Administration (TGA) confirmed this week the supply had returned to normal following a worldwide shortage that lasted almost a year. Issues with overseas manufacturers of the Mylan product in April 2018 had international ramifications, forcing those with…

Read More

Dr John Skerrit appointed as new head of TGA

VIVA! Communications welcomes The Commonwealth Department of Health and Ageing’s (DoHA) appointment of Dr John Skerritt as the new National Manager of the Therapeutic Goods Administration (TGA), effective at the end of May. The TGA is the national body responsible for regulating therapeutic goods including medicines, medical devices, blood and blood products. According to the Secretary…

Read More